glavamin inf. sol. i.v.
fresenius kabi sa-nv - asparagine 3,4 mg/ml; glutamic acid 5,6 mg/ml; valine 7,3 mg/ml; arginine 11,3 mg/ml; leucine 7,9 mg/ml; serine 4,5 mg/ml; proline 6,8 mg/ml; alanine 16 mg/ml; lysine acetate 12,7 mg/ml - eq. lysine 9 mg/ml; histidine 6,8 mg/ml; threonine 5,6 mg/ml; tryptophan 1,9 mg/ml; glycyl-l-glutamine 30,27 mg/ml; glycyl-l-tyrosine 3,45 mg/ml; isoleucine 5,6 mg/ml; methionine 5,6 mg/ml; phenylalanine 5,85 mg/ml - solution for infusion - glycyl-l-glutamine 30.27 mg/ml; histidine 6.8 mg/ml; glutamic acid 5.6 mg/ml; glycyl-l-tyrosine 3.45 mg/ml; leucine 7.9 mg/ml; isoleucine 5.6 mg/ml; methionine 5.6 mg/ml; lysine acetate 12.7 mg/ml; phenylalanine 5.85 mg/ml; proline 6.8 mg/ml; serine 4.5 mg/ml; threonine 5.6 mg/ml; tryptophan 1.9 mg/ml; alanine 16 mg/ml; asparagine 3.4 mg/ml; arginine 11.3 mg/ml; valine 7.3 mg/ml - amino acids
glamin infusion
fresenius kabi malaysia sdn. bhd - alanine; aspartic acid; isoleucine; glutamic acid; arginine; leucine; histidine; methionine; phenylalanine; proline; serine; threonine; tryptophan; valine; lysine acetate; glycyl-l-glutamine h20; glycyl-l-tyrosine 2h20 -
glamin
fresenius kabi new zealand limited - alanine 16 g/l; ; ; ; arginine 11.3 g/l; ; ; aspartic acid 3.4 g/l; ; ; glutamic acid 5.6 g/l; ; ; glycyl-l-glutamine 30.27 g/l; ; glycyl-l-tyrosine 3.45 g/l; histidine 6.8 g/l; ; ; isoleucine 5.6 g/l; ; ; ; leucine 7.9 g/l; ; ; ; lysine acetate 12.7 g/l; ; ; ; methionine 5.6 g/l; ; phenylalanine 5.85 g/l; ; ; ; ; proline 6.8 g/l; ; serine 4.5 g/l; ; ; ; threonine 5.6 g/l; ; ; ; tryptophan 1.9 g/l; ; ; valine 7.3 g/l; ; - solution for infusion - 134 g/l - active: alanine 16 g/l arginine 11.3 g/l aspartic acid 3.4 g/l glutamic acid 5.6 g/l glycyl-l-glutamine 30.27 g/l glycyl-l-tyrosine 3.45 g/l histidine 6.8 g/l isoleucine 5.6 g/l leucine 7.9 g/l lysine acetate 12.7 g/l methionine 5.6 g/l phenylalanine 5.85 g/l proline 6.8 g/l serine 4.5 g/l threonine 5.6 g/l tryptophan 1.9 g/l valine 7.3 g/l excipient: citric acid monohydrate water for injection - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate to severe catabolic status.
glamin %v/v solution for infusion
fresenius kabi limited - alanine arginine aspartic acid glutamic acid glycyl - glutamine monohydrate glycyl -tyrosine dihydrate histidine isoleucine leucine lysine acetate methionine phenylalanine proline serine threonine tryptophan, l- valine - solution for infusion - %v/v
glamin 250 millilitre solution for infusion
fresenius kabi limited - alanine arginine aspartic acid glutamic acid glycyl - glutamine monohydrate glycyl -tyrosine dihydrate histidine isoleucine leucine lysine acetate methionine phenylalanine proline serine threonine tryptophan, l- valine - solution for infusion - 250 millilitre
glamin
fresenius kabi australia pty limited - phenylalanine; tryptophan; alanine; glycylglutamine monohydrate; valine; aspartic acid; serine; glutamic acid; glycyltyrosine dihydrate; histidine; leucine; isoleucine; methionine; lysine acetate; proline; threonine; arginine -
glamin amino acids/dipeptides 1000ml intravenous infusion injection bottle
fresenius kabi australia pty ltd - alanine, quantity: 16 g/l; glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glutamine, qty 20 g); histidine, quantity: 6.8 g/l; methionine, quantity: 5.6 g/l; tryptophan, quantity: 1.9 g/l; threonine, quantity: 5.6 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: glycine, qty 10.27 g; equivalent: lysine, qty 9 g); valine, quantity: 7.3 g/l; arginine, quantity: 11.3 g/l; glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; glutamic acid, quantity: 5.6 g/l; leucine, quantity: 7.9 g/l; isoleucine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l; phenylalanine, quantity: 5.85 g/l - injection, intravenous infusion - excipient ingredients: water for injections; citric acid - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.
glamin amino acids/dipeptides 500ml intravenous infusion injection bottle
fresenius kabi australia pty ltd - proline, quantity: 6.8 g/l; isoleucine, quantity: 5.6 g/l; methionine, quantity: 5.6 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g; equivalent: glycine, qty 10.27 g); serine, quantity: 4.5 g/l; glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glycine, qty 10.27 g; equivalent: glutamine, qty 20 g); alanine, quantity: 16 g/l; histidine, quantity: 6.8 g/l; glutamic acid, quantity: 5.6 g/l; tryptophan, quantity: 1.9 g/l; leucine, quantity: 7.9 g/l; valine, quantity: 7.3 g/l; aspartic acid, quantity: 3.4 g/l; phenylalanine, quantity: 5.85 g/l; glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); arginine, quantity: 11.3 g/l; threonine, quantity: 5.6 g/l - injection, intravenous infusion - excipient ingredients: citric acid; water for injections - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.
nephrotect inf. sol. i.v. vial
fresenius kabi sa-nv - glycine 5,31 mg/ml; valine 8,7 mg/ml; arginine 8,2 mg/ml; leucine 12,8 mg/ml; serine 7,6 mg/ml; proline 3 mg/ml; alanine 6,2 mg/ml; lysine acetate 16,9 mg/ml - eq. lysine 12 mg/ml; histidine 9,8 mg/ml; threonine 8,2 mg/ml; tryptophan 3 mg/ml; glycyl-l-tyrosine 3,16 mg/ml; tyrosine 0,6 mg/ml; isoleucine 5,8 mg/ml; methionine 2 mg/ml; phenylalanine 3,5 mg/ml; acetylcysteine 0,54 mg/ml - solution for infusion - glycine 5.31 mg/ml; isoleucine 5.8 mg/ml; glycyl-l-tyrosine 3.16 mg/ml; histidine 9.8 mg/ml; methionine 2 mg/ml; lysine acetate 16.9 mg/ml; leucine 12.8 mg/ml; phenylalanine 3.5 mg/ml; serine 7.6 mg/ml; proline 3 mg/ml; threonine 8.2 mg/ml; tryptophan 3 mg/ml; tyrosine 0.6 mg/ml; acetylcysteine 0.54 mg/ml; alanine 6.2 mg/ml; arginine 8.2 mg/ml; valine 8.7 mg/ml - amino acids
glamin amino acids/dipeptides 250ml intravenous infusion injection bottle
fresenius kabi australia pty ltd - glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); histidine, quantity: 6.8 g/l; alanine, quantity: 16 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g; equivalent: glycine, qty 10.27 g); glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glutamine, qty 20 g; equivalent: glycine, qty 10.27 g); glutamic acid, quantity: 5.6 g/l; phenylalanine, quantity: 5.85 g/l; valine, quantity: 7.3 g/l; leucine, quantity: 7.9 g/l; tryptophan, quantity: 1.9 g/l; methionine, quantity: 5.6 g/l; isoleucine, quantity: 5.6 g/l; serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; arginine, quantity: 11.3 g/l; threonine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l - injection, intravenous infusion - excipient ingredients: citric acid; water for injections - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.